T-cell immunoglobulin- and mucin-domain-containing molecule 3 signaling blockade improves cell-mediated immunity against malaria

Journal of Infectious Diseases

Volumn 214, Issue 10, 2016, Pages 1547-1556

  Hou, Nan ^a   Zou, Yang ^b   Piao, Xianyu ^a   Liu, Shuai ^a   Wang, Lei ^b   Li, Shanshan ^a   Chen, Qijun ^a,c  

^a INSTITUTE OF PATHOGEN BIOLOGY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c SHENYANG AGRICULTURAL UNIVERSITY   (China)

Author keywords

cell mediated immunity; lymphocyte exhaustion; malaria; Plasmodium berghei ANKA; Plasmodium falciparum; Tim 3

Indexed keywords

PROTEIN ANTIBODY; REGULATOR PROTEIN; T CELL IMMUNOGLOBULIN AND MUCIN DOMAIN CONTAINING MOLECULE 3; UNCLASSIFIED DRUG; HAVCR2 PROTEIN, HUMAN; HAVCR2 PROTEIN, MOUSE; HEPATITIS A VIRUS CELLULAR RECEPTOR 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR IMMUNITY; CEREBRAL MALARIA; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; IMMUNOREGULATION; IN VIVO STUDY; INTRACELLULAR SIGNALING; LYMPHOCYTE SUBPOPULATION; MALARIA; MALARIA FALCIPARUM; MALE; MOUSE; NONHUMAN; PARASITE CLEARANCE; PLASMODIUM BERGHEI INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; UPREGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; IMMUNOLOGY; METABOLISM; NORMAL HUMAN; PLASMODIUM BERGHEI; PLASMODIUM FALCIPARUM;

ANIMALS; HEALTHY VOLUNTEERS; HEPATITIS A VIRUS CELLULAR RECEPTOR 2; HUMANS; IMMUNITY, CELLULAR; MALARIA; MALE; MICE, INBRED C57BL; PLASMODIUM BERGHEI; PLASMODIUM FALCIPARUM;

EID: 85006467520     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiw428     Document Type: Article

References (42)

1. Kumar S, Miller LH. Cellular mechanisms in immunity to blood stage infection. Immunol Lett 1990; 25:109-14.
2. Weidanz WP, Grun JL. Antibody-independent mechanisms in the development of acquired immunity to malaria. Adv Exp Med Biol 1983; 162:409-23.
3. Grun JL, Weidanz WP. Immunity to Plasmodium chabaudi adami in the B-celldeficient mouse. Nature 1981; 290:143-5.
4. von der Weid T, Honarvar N, Langhorne J. Gene-Targeted mice lacking B cells are unable to eliminate a blood stage malaria infection. J Immunol 1996; 156:2510-6.
5. Troye-Blomberg M, Berzins K, Perlmann P. T-cell control of immunity to the asexual blood stages of the malaria parasite. Crit Rev Immunol 1994; 14:131-55.
6. Wykes MN, Horne-Debets JM, Leow CY, Karunarathne DS. Malaria drives T cells to exhaustion. Front Microbiol 2014; 5:249.
7. Freitas do Rosario AP, Muxel SM, Rodriguez-Malaga SM, et al. Gradual decline in malaria-specific memory T cell responses leads to failure to maintain long-Term protective immunity to Plasmodium chabaudi AS despite persistence of B cell memory and circulating antibody. J Immunol 2008; 181:8344-55.
8. Stevenson MM, Riley EM. Innate immunity to malaria. Nat Rev Immunol 2004; 4:169-80.
9. Mohan K, Moulin P, Stevenson MM. Natural killer cell cytokine production, not cytotoxicity, contributes to resistance against blood-stage Plasmodium chabaudi AS infection. J Immunol 1997; 159:4990-8.
10. Tran TM, Li S, Doumbo S, et al. An intensive longitudinal cohort study of Malian children and adults reveals no evidence of acquired immunity to Plasmodium falciparum infection. Clin Infect Dis 2013; 57:40-7.
11. Hirunpetcharat C, Good MF. Deletion of Plasmodium berghei-specific CD4+ T cells adoptively transferred into recipient mice after challenge with homologous parasite. Proc Natl Acad Sci U S A 1998; 95:1715-20.
12. Wipasa J, Xu H, Stowers A, Good MF. Apoptotic deletion of Th cells specific for the 19-kDa carboxyl-Terminal fragment of merozoite surface protein 1 during malaria infection. J Immunol 2001; 167:3903-9.
13. Hansen DS, D Ombrain MC, Schofield L. The role of leukocytes bearing Natural Killer Complex receptors and Killer Immunoglobulin-like Receptors in the immunology of malaria. Curr Opin Immunol 2007; 19:416-23.
14. Freeman GJ, Casasnovas JM, Umetsu DT, DeKruyff RH. TIM genes: a family of cell surface phosphatidylserine receptors that regulate innate and adaptive immunity. Immunol Rev 2010; 235:172-89.
15. Monney L, Sabatos CA, Gaglia JL, et al. Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature 2002; 415:536-41.
16. Sakai K, Kawata E, Ashihara E, et al. Galectin-9 ameliorates acute GVH disease through the induction of T-cell apoptosis. Eur J Immunol 2011; 41:67-75.
17. Bi S, Hong PW, Lee B, Baum LG. Galectin-9 binding to cell surface protein disulfide isomerase regulates the redox environment to enhance T-cell migration and HIV entry. Proc Natl Acad Sci U S A 2011; 108:10650-5.
18. Sabatos CA, Chakravarti S, Cha E, et al. Interaction of Tim-3 and Tim-3 ligand regulates T helper type 1 responses and induction of peripheral tolerance. Nat Immunol 2003; 4:1102-10.
19. Hou N, Piao X, Liu S, Wu C, Chen Q. Tim-3 induces Th2-biased immunity and alternative macrophage activation during Schistosoma japonicum infection. Infect Immun 2015; 83:3074-82.
20. Jones RB, Ndhlovu LC, Barbour JD, et al. Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection. J Exp Med 2008; 205:2763-79.
21. Sakuishi K, Jayaraman P, Behar SM, Anderson AC, Kuchroo VK. Emerging Tim-3 functions in antimicrobial and tumor immunity. Trends Immunol 2012; 32:345-9.
22. Ju Y, Hou N, Meng J, et al. T cell immunoglobulin-and mucin-domain-containing molecule-3 (Tim-3) mediates natural killer cell suppression in chronic hepatitis B. J Hepatol 2010; 52:322-9.
23. Hou N, Zhao D, Liu Y, et al. Increased expression of T cell immunoglobulin-and mucin domain-containing molecule-3 on natural killer cells in atherogenesis. Atherosclerosis 2012; 222:67-73.
24. Zhang Y, Ma CJ, Wang JM, et al. Tim-3 regulates pro-and anti-inflammatory cytokine expression in human CD14+ monocytes. J Leukoc Biol 2012; 91: 189-96.
25. Foks AC, Ran IA, Wasserman L, et al. T-cell immunoglobulin and mucin domain 3 acts as a negative regulator of atherosclerosis. Arterioscler Thromb Vasc Biol 2013; 33:2558-65.
26. Costa PA, Leoratti FM, Figueiredo MM, et al. Induction of inhibitory receptors on T cells during Plasmodium vivax malaria impairs cytokine production. J Infect Dis 2015; 212:1999-2010.
27. Huang B, Liu M, Huang S, et al. Expression of Tim-1 and Tim-3 in Plasmodium berghei ANKA infection. Parasitol Res 2013; 112:2713-9.
28. Xiao S, Liu J, Huang S, Lu F. Increased Gal-9 and Tim-3 expressions during liver damage in a murine malarial model. Parasitol Res 2015; 115:663-72.
29. Liu J, Xiao S, Huang S, Pei F, Lu F. Upregulated Tim-3/galectin-9 expressions in acute lung injury in a murine malarial model. Parasitol Res 2015; 115:587-95.
30. Kimura M, Kaneko O, Liu Q, et al. Indentification of the four species of human malaria parasites by nested PCR that targets variant sequences in the small subunit rRNA gene. Parasitol Int 1997; 46:91-5.
31. Carroll RW, Wainwright MS, Kim KY, et al. A rapid murine coma and behavior scale for quantitative assessment of murine cerebral malaria. PLoS One 2010; 5: e13124.
32. Chang Z, Jiang N, Zhang Y, et al. The TatD-like DNase of Plasmodium is a virulence factor and a potential malaria vaccine candidate. Nat Commun 2016; 7:11537.
33. Fernandez V, Treutiger CJ, Nash GB, Wahlgren M. Multiple adhesive phenotypes linked to rosetting binding of erythrocytes in Plasmodium falciparum malaria. Infect Immun 1998; 66:2969-75.
34. New estimates of malaria deaths: concern and opportunity. Lancet 2012; 379:385.
35. Day CL, Kaufmann DE, Kiepiela P, et al. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 2006; 443:350-4.
36. Urbani S, Amadei B, Tola D, et al. PD-1 expression in acute hepatitis C virus (HCV) infection is associated with HCV-specific CD8 exhaustion. J Virol 2006; 80:11398-403.
37. Liang SC, Greenwald RJ, Latchman YE, et al. PD-L1 and PD-L2 have distinct roles in regulating host immunity to cutaneous leishmaniasis. Eur J Immunol 2006; 36:58-64.
38. Butler NS, Moebius J, Pewe LL, et al. Therapeutic blockade of PD-L1 and LAG-3 rapidly clears established blood-stage Plasmodium infection. Nat Immunol 2011; 13:188-95.
39. Schofield L, Grau GE. Immunological processes in malaria pathogenesis. Nat Rev Immunol 2005; 5:722-35.
40. Romero D. Immunotherapy: PD-1 says goodbye, TIM-3 says hello. Nat Rev Clin Oncol 2016; 13:202-3.
41. Jayaraman P, Sada-Ovalle I, Beladi S, et al. Tim3 binding to galectin-9 stimulates antimicrobial immunity. J Exp Med 2010; 207:2343-54.
42. Klibi J, Niki T, Riedel A, et al. Blood diffusion and Th1-suppressive effects of galectin-9-containing exosomes released by Epstein-Barr virus-infected nasopharyngeal carcinoma cells. Blood 2009; 113:1957-66.